Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes If you ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Weight loss remains a hot area ...
File sharing between devices can feel complicated if you’ve never given it much thought. But, in reality, that couldn’t be further from the truth. Quick Share makes sending and receiving whatever ...
“As a collector with over 62,000 cards, Yu-Gi-Oh! has been part of my life since childhood,” said FINE CHAOS creative director Marc C. Møllerskov.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback